Sort   by:  
 Page size 
UnknownDevelopment and Application of a Novel Model System to Study "Active" and "Passive" Tumor Targeting.
Not available
S-EPMC5050124 | biostudies-literature
UnknownATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors.
Not available
S-EPMC8997088 | biostudies-literature
UnknownTherapeutic Vulnerability to ATR Inhibition in Concurrent NF1 and ATRX-Deficient/ALT-Positive High-Grade Solid Tumors.
Not available
S-EPMC9221513 | biostudies-literature
UnknownDownregulation of 5-hydroxymethylcytosine is an early event in pancreatic tumorigenesis.
Not available
S-EPMC9516434 | biostudies-literature
UnknownDAXX promotes centromeric stability independently of ATRX by preventing the accumulation of R-loop-induced DNA double-stranded breaks.
Not available
S-EPMC10853780 | biostudies-literature
UnknownComprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer.
Not available
S-EPMC5971230 | biostudies-literature
UnknownATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization.
Not available
S-EPMC8759735 | biostudies-literature
UnknownIpilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer.
Not available
S-EPMC6033362 | biostudies-literature
UnknownLoss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
Not available
S-EPMC3400581 | biostudies-literature
UnknownA checklist for assessing the methodological quality of concurrent tES-fMRI studies (ContES checklist): a consensus study and statement.
Not available
S-EPMC7612687 | biostudies-literature
Sort   by:  
 Page size